Package 51672-4136-9

{"route": ["ORAL"], "spl_id": "559a39a2-ec8e-443b-9df0-4c909633981c", "openfda": {"nui": ["N0000008486"], "upc": ["0351672414160"], "unii": ["44YRR34555"], "rxcui": ["311288", "311289", "311290", "387003", "403884"], "spl_set_id": ["bf412e94-ca36-4da9-83d7-fb0f1323cf21"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["Taro Pharmaceuticals U.S.A., Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "3785 mL in 1 BOTTLE (51672-4136-0)", "package_ndc": "51672-4136-0", "marketing_start_date": "20090210"}, {"sample": false, "description": "100 mL in 1 BOTTLE (51672-4136-7)", "package_ndc": "51672-4136-7", "marketing_start_date": "20090210"}, {"sample": false, "description": "473 mL in 1 BOTTLE (51672-4136-9)", "package_ndc": "51672-4136-9", "marketing_start_date": "20090210"}], "brand_name": "Levetiracetam", "product_id": "51672-4136_559a39a2-ec8e-443b-9df0-4c909633981c", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "51672-4136", "generic_name": "Levetiracetam", "labeler_name": "Taro Pharmaceuticals U.S.A., Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Levetiracetam", "active_ingredients": [{"name": "LEVETIRACETAM", "strength": "100 mg/mL"}], "application_number": "ANDA078774", "marketing_category": "ANDA", "marketing_start_date": "20090210", "listing_expiration_date": "20261231"}